International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 5 , Pages 1322-1328 , 1 August 2010

The Impact of Acute Urinary Retention After Iodine-125 Prostate Brachytherapy on Health-Related Quality of Life

  • Ellen M.A. Roeloffzen, M.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • Corresponding Author InformationReprint requests to: Ellen Roeloffzen, M.D., Department of Radiation Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Tel: (+31) 887558800; Fax: (+31) 887555850
    • ,
  • Karel A. Hinnen, M.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Jan J. Battermann, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Evelyn M. Monninkhof, Ph.D.

      Affiliations

    • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Joep G.H. van Roermund, M.D.

      Affiliations

    • Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Marion P.R. van Gellekom, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Steven J. Frank, M.D.

      Affiliations

    • Department of Radiation Oncology, M. D. Anderson Medical Center, Houston, TX
    • ,
  • Marco van Vulpen, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Received 15 May 2009 ,Revised 25 June 2009 ,Accepted 29 June 2009.

References 

  1. Zelefsky MJ, Kuban DA, Levy LB, et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys. 2007;67:327–333
  2. Potters L, Morgenstern C, Calugaru E, et al. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol. 2008;179:S20–S24
  3. Hinnen KA, Battermann JJ, Vulpen M, et al. Long term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2009 Jun 17;[Epub ahead of print]
  4. Peschel RE, Colberg JW. Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol. 2003;4:233–241
  5. Miller DC, Sanda MG, Dunn RL, et al. Long-term outcomes among localized prostate cancer survivors: Health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005;23:2772–2780
  6. Terk MD, Stock RG, Stone NN. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol. 1998;160:1379–1382
  7. Lee N, Wuu CS, Brody R, et al. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000;48:1457–1460
  8. Bucci J, Morris WJ, Keyes M, et al. Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2002;53:91–98
  9. Crook J, McLean M, Catton C, et al. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys. 2002;52:453–460
  10. Locke J, Ellis W, Wallner K, et al. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study. Int J Radiat Oncol Biol Phys. 2002;52:712–719
  11. Keyes M, Schellenberg D, Moravan V, et al. Decline in urinary retention incidence in 805 patients after prostate brachytherapy: The effect of learning curve?. Int J Radiat Oncol Biol Phys. 2006;64:825–834
  12. Kollmeier MA, Stock RG, Cesaretti J, et al. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy. J Urol. 2005;173:808–812
  13. Ikuerowo SO, Ogunade AA, Ogunlowo TO, et al. The burden of prolonged indwelling catheter after acute urinary retention in Ikeja - Lagos, Nigeria. BMC Urol. 2007;7:16
  14. Gelblum DY, Potters L, Ashley R, et al. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys. 1999;45:59–67
  15. Thomas MD, Cormack R, Tempany CM, et al. Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000;47:905–908
  16. Roeloffzen EMA, Lips IM, Van Gellekom MPR, et al. Health-related quality of life up to six years after I-125 brachytherapy for early-stage prostate cancer. Int J Radiat Oncol Biol Phys. Accepted for publication.
  17. Ash D, Flynn A, Battermann J, et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol. 2000;57:315–321
  18. Nath R, Anderson LL, Luxton G, et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys. 1995;22:209–234
  19. Hornbrook MC, Goodman MJ. Assessing relative health plan risk with the RAND-36 health survey. Inquiry. 1995;32:56–74
  20. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376
  21. Borghede G, Sullivan M. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res. 1996;5:212–222
  22. Barry MJ, Fowler FJ, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148:1549–1557
  23. Van Andel G, Bottomley A, Fossa SD, et al. An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 2008;44:2418–2424
  24. Steyerberg EW, Eijkemans MJ, Harrell FE, et al. Prognostic modeling with logistic regression analysis: In search of a sensible strategy in small data sets. Med Decis Making. 2001;21:45–56
  25. Merrick GS, Butler WM, Wallner KE, et al. Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2004;58:81–88
  26. Anderson JF, Swanson DA, Levy LB, et al. Urinary side effects and complications following prostate brachytherapy: The M.D. Anderson Cancer Center experience. Urology. In press.

 Conflict of interest: none.

PII: S0360-3016(09)02796-5

doi: 10.1016/j.ijrobp.2009.06.083

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 5 , Pages 1322-1328 , 1 August 2010

Article Tools

* Image Usage & Resolution